FISH demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosis

Rafael Fonseca, S Vincent Rajkumar, G. J. Ahmann, S. M. Jalal, James Hoyer, Morie Gertz, R. A. Kyle, P. R. Greipp, G. W. Dewald

Research output: Contribution to journalArticle

9 Scopus citations


Conventional cytogenetic analysis is limited in the evaluation of plasma cell disorders because, relative to normal hematopoietic elements, plasma cells divide slowly. Moreover, it is difficult to know whether abnormal metaphases originate from malignant plasma cells or myeloid cells harboring other abnormalities. We studied a patient with primary systemic amyloidosis who had previously been treated with an alkylating agent. Bone marrow cells were analyzed by cytoplasmic-immunoglobulin fluorescent staining combined with fluorescent in situ hybridization (cIg-FISH). Both chromosome enumeration probes chromosome 1 and 7 and loci-specific probes for the short and long arm chromosome 7 were used. Cytogenetic analysis disclosed the following abnormality: +der(1;7)(q10;p10). On cIg-FISH, the myeloid cells had fusion signals between chromosome enumeration probes for chromosomes 1 and 7, whereas plasma cells had the normal appearance of two pairs of signals. There was a second clone of abnormal myeloid cells with monosomy of chromosome 7. The bone marrow did not show any evidence of myelodysplasia. Interphase cIg-FISH is a useful technique for assigning the lineage of chromosomal abnormalities in plasma cell disorders.

Original languageEnglish (US)
Pages (from-to)391-395
Number of pages5
JournalLeukemia and Lymphoma
Issue number3-4
StatePublished - 2000



  • Amyloidosis
  • Aneuploidy
  • Monoclonal gammopathies
  • Multiple myeloma
  • Myelodysplasia
  • Paraproteinemias

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this